Macroaxis: Personalized Investing

Personalized Investing and

Digital Wealth Optimization

Benchmark  United States  NYSE  10,537   154.414 Index Moved Down -1.44%  

Collecting data for DGM

Diagnostic valuation Diagnostic valuation


Diagnostic Medical S

Stock@Paris Stock Exchange 
France EUR
(0.01) times
Diagnostic seems to be fairly valued based on Macroaxis valuation methodology. Macroaxis computes value of Diagnostic Medical S from reviewing the firm fundamentals such as Operating Margin of (0.94)%, Profit Margin of (4.08)% and Current Valuation of 14.09M as well as analyzing its technical indicators and Probability Of Bankruptcy. In general, we advise to go long with undervalued instruments and to sell out overvalued instruments since at some point assets prices and their ongoing real values will submerge.
change horizon
Investment horizon:  
  30 Days    Login   to change

Diagnostic Total Value Analsys

Diagnostic Medical Systems SA is currently anticipated to have takeover price of 14.09 M with market capitalization of 12.64 M, debt of 2.71 M, and cash on hands of 2.84 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Diagnostic fundamentals before making investing decisions based on the enterprise value of the company
  Takeover PriceMarket CapDebt ObligationsCash
14.09 M12.64 M2.71 M2.84 M

Diagnostic Investor Information

The company has price-to-book (P/B) ratio of 1.0. Some equities with similar Price to Book (P/B) outperform the market in the long run. Diagnostic Medical Systems SA recorded loss per share of 0.01. This company had not issued any dividends in recent years. Diagnostic Medical Systems S.A. manufactures and distributes imaging systems for conventional and digital radiology, and bone densitometry applications worldwide. To learn more about DMS call Jean-Paul Ansel at 33 4 67 50 49 00 or check out

Diagnostic Asset Utilization

Diagnostic Medical Systems SA shows negative operation of assets of -0.67 percent, getting only €0.01 for each euro of assets held by the firm. Unsuccessful assets utilization denotes the company is being less effective with each euro of assets it shows. In plain English assets utilization of Diagnostic Medical Systems SA shows how unproductive it operates for each euro spent on its assets.

Diagnostic Profitability Analysis

The company reported revenue of 23.51 M. Net Loss for the year was (959 K) with profit before overhead, payroll, taxes, and interest of 8 M.
Benchmark  Embed   Values 

Diagnostic Debt Analysis

DMS has accumulated about 2.84 M in cash with 112 K of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.04.
The company has accumulated 2.71 M in total debt with debt to equity ratio (D/E) of 0.21 which may suggest the company is not taking enough advantage from borrowing. Diagnostic Medical Systems SA has Current Ratio of 2.33 suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due.